During the past decade, Azienda Ospedaliera Pugliese Ciaccio conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 12 clinical trials were completed, i.e. on average, 46.2% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Azienda Ospedaliera Pugliese Ciaccio" #1 sponsor was "University Magna Graecia" with 29 trials, followed by "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 28 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 6 trials sponsored, "Azienda Ospedaliera Cardinale G. Panico" with 5 trials sponsored and "Associazione Angela Serra per la ricerca sul cancro" with 5 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Ospedaliera Pugliese Ciaccio" #1 collaborator was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 4 trials as a collaborator, "Baxalta Innovations GmbH, now part of Shire" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 2 trials as a collaborator and "Acute Leukemia French Association" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliera Pugliese Ciaccio" are "Leukemia" (13 trials), "Polycystic Ovary Syndrome" (11 trials), "Infertility" (9 trials), "Chronic Lymphocytic Leukemia" (6 trials) and "Heart Failure" (5 trials). Many other conditions were trialed in "Azienda Ospedaliera Pugliese Ciaccio" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliera Pugliese Ciaccio" are "Drug" (56 trials), "Procedure" (17 trials), "Other" (11 trials), "Device" (9 trials) and "Radiation" (6 trials). Other intervention types were less common.

The name of intervention was led by "Metformin" (5 trials), "Placebo" (5 trials), "cytarabine" (5 trials), "idarubicin" (5 trials) and "mercaptopurine" (5 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliera Pugliese Ciaccio" are 66 trials for "All" genders and 32 trials for "Female" genders.

Currently, there are NaN active trials in "Azienda Ospedaliera Pugliese Ciaccio". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 49 completed trials in Azienda Ospedaliera Pugliese Ciaccio, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliera Pugliese Ciaccio, 2 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 29 trials, and there were also 9 trials that are defined as “Not Applicable".

Azienda Ospedaliera Pugliese Ciaccio has several departments that took part in Clinical trials: "Ao Di Catanzaro "Pugliese-Ciaccio", Presidio Ospedaliero "Ciaccio - de Lellis" - Ematologia" - 8 trials, "Ospedale Civile Pugliese - Utic-Emodinamica E Card. Interventistica" - 2 trials, "Az. Osp. Pugliese; Dh Oncologico" - 3 trials